PMV Pharmaceuticals
Presença
PMV Pharmaceuticals é uma das ...
PMV Pharmaceuticals é uma empresa listada sob o símbolo PMVP (US).
Executivos
Veja o organograma con seus 19 executivos principais
Biografias mais buscadas da PMV Pharmaceuticals
- David Mack, Director, President and Chief Executive Officer
- Arnold Levine, Director
- Kirsten Flowers, Director
Recentes movimentos de executivos em PMV Pharmaceuticals
- Leila Alland, Chief Medical Officer, deixou a Companhia (Notícia publicada em 21 de janeiro de 2024).
- Winston Kung, Chief Operating Officer and Chief Financial Officer, deixou a Companhia (Notícia publicada em 8 de janeiro de 2024).
- Michael Carulli antes Senior Vice President, Finance, foi promovido a Chief Financial Officer (Notícia publicada em 8 de janeiro de 2024).
Criar um alerta
para seguir os movimentos de executivos da PMV Pharmaceuticals.
Farmacêutica
PMV Pharmaceuticals possui 1.861 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- MedMen has filed for bankruptcy protection (publicado em 28 de abril de 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de PMV Pharmaceuticals
- PMV Pharmaceuticals Announces a Clinical Trial Collaboration with Merck to Evaluate PC14586 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Initial PC14586 Phase 1 Data Presented at ASCO Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a p53 Y220C Mutation | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Announces Initial PC14586 Phase 1 Clinical Data to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Reports First Quarter 2022 Financial Results and Corporate Highlights | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Present PC14586 Phase 1 Clinical Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Participate in the 42nd Annual Cowen Health Care Conference | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Participate in the Guggenheim Healthcare Talks 2022 Oncology Day | PMV Pharmaceuticals, Inc.
- PMV Pharma Announces Changes to its Board of Directors | PMV Pharmaceuticals, Inc.
- View more press releases Close
Redes sociais sobre PMV Pharmaceuticals
- PMV Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
- PMV Pharmaceuticals na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo David Mack 
Ligue para a PMV Pharmaceuticals em +1 609...
